OpenURL Connection Search

Select item for more details and to access through your institution.

The Richardson/Schlossman/Hideshima et a! Article Reviewed.
Published in:
Oncology (08909091), 2005, v. 19, n. 14, p. 1792
By:
- Kaufman, Jonathan L.
Publication type:
Article
Quadruplet therapy for newly diagnosed myeloma: comparative analysis of sequential cohorts with triplet therapy lenalidomide, bortezomib and dexamethasone (RVd) versus daratumamab with RVD (DRVd) in transplant-eligible patients.
Published in:
Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01120-9
By:
- Joseph, Nisha S.;
- Kaufman, Jonathan L.;
- Gupta, Vilas A.;
- Hofmeister, Craig C.;
- Dhodapkar, Madhav V.;
- Boise, Lawrence H.;
- DiCamillo, Sara M.;
- Roberts, Danielle;
- Nooka, Ajay K.;
- Lonial, Sagar
Publication type:
Article
Daratumumab in transplant-eligible patients with newly diagnosed multiple myeloma: final analysis of clinically relevant subgroups in GRIFFIN.
Published in:
Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01088-6
By:
- Chari, Ajai;
- Kaufman, Jonathan L.;
- Laubach, Jacob;
- Sborov, Douglas W.;
- Reeves, Brandi;
- Rodriguez, Cesar;
- Silbermann, Rebecca;
- Costa, Luciano J.;
- Anderson Jr, Larry D.;
- Nathwani, Nitya;
- Shah, Nina;
- Bumma, Naresh;
- Holstein, Sarah A.;
- Costello, Caitlin;
- Jakubowiak, Andrzej;
- Wildes, Tanya M.;
- Orlowski, Robert Z.;
- Shain, Kenneth H.;
- Cowan, Andrew J.;
- Pei, Huiling
Publication type:
Article
Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic risk.
Published in:
Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01030-w
By:
- Callander, Natalie S.;
- Silbermann, Rebecca;
- Kaufman, Jonathan L.;
- Godby, Kelly N.;
- Laubach, Jacob;
- Schmidt, Timothy M.;
- Sborov, Douglas W.;
- Medvedova, Eva;
- Reeves, Brandi;
- Dhakal, Binod;
- Rodriguez, Cesar;
- Chhabra, Saurabh;
- Chari, Ajai;
- Bal, Susan;
- Anderson Jr, Larry D.;
- Dholaria, Bhagirathbhai R.;
- Nathwani, Nitya;
- Hari, Parameswaran;
- Shah, Nina;
- Bumma, Naresh
Publication type:
Article
Prophylactic tocilizumab to prevent cytokine release syndrome (CRS) with teclistamab: A single-center experience.
Published in:
Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00963-y
By:
- Scott, Sara A.;
- Marin, Ellen M.;
- Maples, Kathryn T.;
- Joseph, Nisha S.;
- Hofmeister, Craig C.;
- Gupta, Vikas A.;
- Dhodapkar, Madhav V.;
- Kaufman, Jonathan L.;
- Lonial, Sagar;
- Nooka, Ajay K.
Publication type:
Article
Novel Treatment Approaches for Patients with Multiple Myeloma.
Published in:
Clinical Lymphoma & Myeloma, 2006, v. 6, n. 4, p. 281
By:
- Sinha, Rajni;
- Kaufman, Jonathan L.;
- Lonial, Sagar
Publication type:
Article
Preferences and Priorities for Relapsed Multiple Myeloma Treatments Among Patients and Caregivers in the United States.
Published in:
Patient Preference & Adherence, 2022, v. 16, p. 573, doi. 10.2147/PPA.S345906
By:
- Auclair, Daniel;
- Mansfield, Carol;
- Fiala, Mark A;
- Chari, Ajai;
- Cole, Craig E;
- Kaufman, Jonathan L;
- Orloff, Gregory J;
- Siegel, David S;
- Zonder, Jeffrey A;
- Mange, Brennan;
- Yesil, Jennifer;
- Dalal, Mehul;
- Mikhael, Joseph R
Publication type:
Article
Post hoc analysis of daratumumab plus lenalidomide, bortezomib and dexamethasone in Black patients from final data of the GRIFFIN study.
Published in:
British Journal of Haematology, 2024, v. 204, n. 6, p. 2227, doi. 10.1111/bjh.19386
By:
- Nooka, Ajay K.;
- Kaufman, Jonathan L.;
- Rodriguez, Cesar;
- Jakubowiak, Andrzej;
- Efebera, Yvonne;
- Reeves, Brandi;
- Wildes, Tanya M.;
- Holstein, Sarah A.;
- Anderson, Larry D.;
- Badros, Ashraf;
- Shune, Leyla;
- Chari, Ajai;
- Pei, Huiling;
- Cortoos, Annelore;
- Patel, Sharmila;
- Lin, Thomas S.;
- Voorhees, Peter M.;
- Usmani, Saad Z.;
- Richardson, Paul G.
Publication type:
Article
Daratumumab plus lenalidomide, bortezomib and dexamethasone in newly diagnosed multiple myeloma: Analysis of vascular thrombotic events in the GRIFFIN study.
Published in:
British Journal of Haematology, 2022, v. 199, n. 3, p. 355, doi. 10.1111/bjh.18432
By:
- Sborov, Douglas W.;
- Baljevic, Muhamed;
- Reeves, Brandi;
- Laubach, Jacob;
- Efebera, Yvonne A.;
- Rodriguez, Cesar;
- Costa, Luciano J.;
- Chari, Ajai;
- Silbermann, Rebecca;
- Holstein, Sarah A.;
- Anderson, Larry D.;
- Kaufman, Jonathan L.;
- Shah, Nina;
- Pei, Huiling;
- Patel, Sharmila;
- Cortoos, Annelore;
- Bartlett, J. Blake;
- Vermeulen, Jessica;
- Lin, Thomas S.;
- Voorhees, Peter M.
Publication type:
Article
A phase II study of bortezomib added to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone in patients with previously untreated indolent non-Hodgkin's lymphoma.
Published in:
British Journal of Haematology, 2015, v. 171, n. 4, p. 539, doi. 10.1111/bjh.13637
By:
- Cohen, Jonathon B.;
- Switchenko, Jeffrey M.;
- Koff, Jean L.;
- Sinha, Rajni;
- Kaufman, Jonathan L.;
- Khoury, H. Jean;
- Bumpers, Nassoma;
- Colbert, Amanda;
- Hutchison‐Rzepka, Amanda;
- Nastoupil, Loretta J.;
- Heffner, Leonard T.;
- Langston, Amelia A.;
- Lechowicz, Mary Jo;
- Lonial, Sagar;
- Flowers, Christopher R.
Publication type:
Article
Phase I, multicentre, dose-escalation trial of monotherapy with milatuzumab (humanized anti-CD74 monoclonal antibody) in relapsed or refractory multiple myeloma.
Published in:
British Journal of Haematology, 2013, v. 163, n. 4, p. 478, doi. 10.1111/bjh.12565
By:
- Kaufman, Jonathan L.;
- Niesvizky, Ruben;
- Stadtmauer, Edward A.;
- Chanan‐Khan, Asher;
- Siegel, David;
- Horne, Heather;
- Wegener, William A.;
- Goldenberg, David M.
Publication type:
Article
Health‐related quality of life in transplant‐eligible patients with newly diagnosed multiple myeloma treated with daratumumab, lenalidomide, bortezomib, and dexamethasone: Patient‐reported outcomes from GRIFFIN.
Published in:
American Journal of Hematology, 2024, v. 99, n. 7, p. 1257, doi. 10.1002/ajh.27326
By:
- Silbermann, Rebecca;
- Laubach, Jacob;
- Kaufman, Jonathan L.;
- Sborov, Douglas W.;
- Reeves, Brandi;
- Rodriguez, Cesar;
- Chari, Ajai;
- Costa, Luciano J.;
- Anderson, Larry D.;
- Nathwani, Nitya;
- Shah, Nina;
- Bumma, Naresh;
- Holstein, Sarah A.;
- Costello, Caitlin;
- Jakubowiak, Andrzej;
- Orlowski, Robert Z.;
- Shain, Kenneth H.;
- Cowan, Andrew J.;
- Gries, Katharine S.;
- Pei, Huiling
Publication type:
Article
Targeting BCL‐2 with venetoclax and dexamethasone in patients with relapsed/refractory t(11;14) multiple myeloma.
Published in:
American Journal of Hematology, 2021, v. 96, n. 4, p. 418, doi. 10.1002/ajh.26083
By:
- Kaufman, Jonathan L.;
- Gasparetto, Cristina;
- Schjesvold, Fredrik H.;
- Moreau, Philippe;
- Touzeau, Cyrille;
- Facon, Thierry;
- Boise, Lawrence H.;
- Jiang, Yanwen;
- Yang, Xiaoqing;
- Dunbar, Fengjiao;
- Vishwamitra, Deeksha;
- Unger, Stefanie;
- Macartney, Tammy;
- Pesko, John;
- Yu, Yao;
- Salem, Ahmed Hamed;
- Ross, Jeremy A.;
- Hong, Wan‐Jen;
- Maciag, Paulo C.;
- Pauff, James M.
Publication type:
Article
Natural history of multiple myeloma patients refractory to venetoclax: A single center experience.
Published in:
American Journal of Hematology, 2021, v. 96, n. 3, p. E68, doi. 10.1002/ajh.26064
By:
- Maples, Kathryn T.;
- Nooka, Ajay K.;
- Gupta, Vikas;
- Joseph, Nisha S.;
- Heffner, Leonard T.;
- Hofmeister, Craig;
- Dhodapkar, Madhav;
- Matulis, Shannon M.;
- Lonial, Sagar;
- Boise, Lawrence H.;
- Kaufman, Jonathan L.
Publication type:
Article
Insights Into the Appropriate Use of New Antimyeloma Therapies.
Published in:
Oncology (08909091), 2017, v. 31, n. 1, p. 64
By:
- Kaufman, Jonathan L.;
- Lonial, Sagar
Publication type:
Article
Non-Secretory Myeloma: A Clinician's Guide.
Published in:
Oncology (08909091), 2013, v. 27, n. 9, p. 924
By:
- LONIAL, SAGAR;
- KAUFMAN, JONATHAN L.
Publication type:
Article
Multiple myeloma immunoglobulin lambda translocations portend poor prognosis.
Published in:
Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-09555-6
By:
- Barwick, Benjamin G.;
- Neri, Paola;
- Bahlis, Nizar J.;
- Nooka, Ajay K.;
- Dhodapkar, Madhav V.;
- Jaye, David L.;
- Hofmeister, Craig C.;
- Kaufman, Jonathan L.;
- Gupta, Vikas A.;
- Auclair, Daniel;
- Keats, Jonathan J.;
- Lonial, Sagar;
- Vertino, Paula M.;
- Boise, Lawrence H.
Publication type:
Article
Multiple Myeloma Presenting with Advanced Renal Failure: A Case Report and New Treatment Options.
Published in:
Clinical Lymphoma & Myeloma, 2008, v. 8, n. 1, p. 52
By:
- Gladney, S. Pierson;
- Lonial, Sagar;
- Kaufman, Jonathan L.
Publication type:
Article
Divergence of variant antibodies following SARS-CoV-2 booster vaccines in myeloma and impact of hybrid immunity.
Published in:
NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-00999-6
By:
- Moreno, Alberto;
- Manning, Kelly;
- Azeem, Maryam I.;
- Nooka, Ajay K.;
- Ellis, Madison;
- Manalo, Renee Julia;
- Switchenko, Jeffrey M.;
- Wali, Bushra;
- Kaufman, Jonathan L.;
- Hofmeister, Craig C.;
- Joseph, Nisha S.;
- Lonial, Sagar;
- Dhodapkar, Kavita M.;
- Dhodapkar, Madhav V.;
- Suthar, Mehul S.
Publication type:
Article
Filanesib plus bortezomib and dexamethasone in relapsed/refractory t(11;14) and 1q21 gain multiple myeloma.
Published in:
Cancer Medicine, 2022, v. 11, n. 2, p. 358, doi. 10.1002/cam4.4451
By:
- Pan, Darren;
- Kaufman, Jonathan L.;
- Htut, Myo;
- Agrawal, Manish;
- Mazumder, Amitabha;
- Cornell, Robert F.;
- Zonder, Jeffrey A.;
- Fay, Joseph W.;
- Modiano, Manuel R.;
- Moshier, Erin L.;
- Rush, Selena A.;
- Tunquist, Brian J.;
- Chari, Ajai
Publication type:
Article
Dermato-neuro syndrome in a patient treated with autologous stem cell transplant for scleromyxedema.
Published in:
2014
By:
- Shams, Samantha R;
- Goldstein, Daniel A;
- Kaufman, Jonathan L;
- MacKelfresh, Jamie;
- Flowers, Christopher R;
- Langston, Amelia A
Publication type:
Journal Article
Optimal dosing of melphalan as high-dose therapy before autologous hematopoietic stem cell transplantation in myeloma patients with solitary kidney: a case series.
Published in:
2014
By:
- Nooka, Ajay K;
- Harvey, R Donald;
- Langston, Amelia;
- Collins, Hannah;
- Lonial, Sagar;
- Kaufman, Jonathan L
Publication type:
Journal Article
Histone Deacetylase Inhibitors in Multiple Myeloma: Rationale and Evidence for Their Use in Combination Therapy.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2013, v. 13, n. 4, p. 370, doi. 10.1016/j.clml.2013.03.016
By:
- Kaufman, Jonathan L.;
- Fabre, Claire;
- Lonial, Sagar;
- Richardson, Paul G.
Publication type:
Article
Bortezomib Administration With Severe Hyperbilirubinemia Caused by Hepatic Plasma Cell Infiltration: A Case Report.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2013, v. 13, n. 2, p. 159, doi. 10.1016/j.clml.2012.09.005
By:
- Wilson, Nicole;
- Surati, Minal;
- Walker, Bruce F.;
- Kaufman, Jonathan L.;
- Donald Harvey, R.
Publication type:
Article
PFS Benefit with Daratumumab Combo Sustained After 4 Years of Follow-Up.
Published in:
Journal of Oncology Navigation & Survivorship, 2020, v. 11, n. 4, p. 118
By:
- Kaufman, Jonathan L.
Publication type:
Article
BCL2 Family Inhibitors in the Biology and Treatment of Multiple Myeloma.
Published in:
Blood & Lymphatic Cancer: Targets & Therapy, 2021, v. 11, p. 11, doi. 10.2147/BLCTT.S245191
By:
- Gupta, Vikas A;
- Ackley, James;
- Kaufman, Jonathan L;
- Boise, Lawrence H
Publication type:
Article
MM-392: Belantamab Mafodotin (Belamaf; GSK2857916) US Expanded Access Program (EAP) for Heavily Pre-Treated Patients with Relapsed/Refractory Multiple Myeloma (RRMM): Baseline Characteristics.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S439, doi. 10.1016/S2152-2650(21)01979-0
By:
- Hultcrantz, Malin;
- Anderson, Larry D.;
- Anwer, Faiz;
- Gasparetto, Cristina;
- Kocoglu, Mehmet H.;
- Lichtman, Eben I.;
- Mo, Clifton;
- Niesvizky, Ruben;
- Lewis, Eric;
- Hong;
- Li;
- Paul, Sofia;
- Petrone, Stephanie;
- Kaufman, Jonathan L.
Publication type:
Article
Poster: MM-392: Belantamab Mafodotin (Belamaf; GSK2857916) US Expanded Access Program (EAP) for Heavily Pre-Treated Patients with Relapsed/Refractory Multiple Myeloma (RRMM): Baseline Characteristics.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S252, doi. 10.1016/S2152-2650(21)01579-2
By:
- Hultcrantz, Malin;
- Anderson, Larry D.;
- Anwer, Faiz;
- Gasparetto, Cristina;
- Kocoglu, Mehmet H.;
- Lichtman, Eben I.;
- Mo, Clifton;
- Niesvizky, Ruben;
- Lewis, Eric;
- Li, Hong;
- Paul, Sofia;
- Petrone, Stephanie;
- Kaufman, Jonathan L.
Publication type:
Article
Phase 1 Trial Evaluating Vorinostat Plus Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma.
Published in:
2020
By:
- Kaufman, Jonathan L.;
- Mina, Roberto;
- Shah, Jatin J.;
- Laubach, Jacob P.;
- Nooka, Ajay K.;
- Lewis, Colleen;
- Gleason, Charise;
- Sharp, Cathy;
- Harvey, R. Donald;
- Heffner, Leonard T.;
- Richardson, Paul;
- Lonial, Sagar;
- Orlowski, Robert Z.
Publication type:
journal article
Daratumumab + Lenalidomide, Bortezomib & Dexamethasone Improves Depth of Response in Transplant-eligible Newly Diagnosed Multiple Myeloma: GRIFFIN.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e353, doi. 10.1016/j.clml.2019.09.583
By:
- Voorhees, Peter;
- Kaufman, Jonathan L.;
- Laubach, Jacob;
- Sborov, Douglas;
- Reeves, Brandi;
- Rodriguez, Cesar;
- Chari, Ajai;
- Silbermann, Rebecca;
- Costa, Luciano;
- Anderson, Larry;
- Nathwani, Nitya;
- Shah, Nina;
- Efebera, Yvonne;
- Costello, Caitlin;
- Jakubowiak, Andrzej;
- Wildes, Tanya;
- Orlowski, Robert Z.;
- Shain, Kenneth H.;
- Cowan, Andrew;
- Murphy, Sean
Publication type:
Article
Phase II Trial of Ixazomib and Dexamethasone Versus Ixazomib, Dexamethasone and Lenalidomide, Randomized with NFKB2 Rearrangement. (Proteasome Inhibitor NFKB2 Rearrangement Driven Trial, PINR).
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e243, doi. 10.1016/j.clml.2019.09.404
By:
- Bernal, Leon;
- Nooka, Ajay;
- Cole, Craig;
- Heffner, Leonard T.;
- Ye, Jing Christine;
- Vij, Ravi;
- Chen, Zhengjia;
- Zhang, Chao;
- Rushton, John;
- Munevver, Cinnar;
- Lonial, Sagar;
- Kaufman, Jonathan L.
Publication type:
Article
Gain of Chromosome 1q is Associated with Early Progression in Multiple Myeloma Patients Treated with Lenalidomide, Bortezomib, and Dexamethasone.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e76, doi. 10.1016/j.clml.2019.09.121
By:
- Schmidt, Timothy;
- Joseph, Nisha;
- Barwick, Benjamin;
- Heffner, Leonard T.;
- Hofmeister, Craig;
- Bernal, Leon;
- Dhodapkar, Madhav;
- Gupta, Vikas;
- Jaye, David;
- Chen, Zhengjia;
- Boise, Lawrence;
- Lonial, Sagar;
- Nooka, Ajay;
- Kaufman, Jonathan L.
Publication type:
Article
A Comparison of the Efficacy of Immunomodulatory-containing Regimens in Relapsed/Refractory Multiple Myeloma: A Network Meta-analysis.
Published in:
2018
By:
- Dimopoulos, Meletios Athanasios;
- Kaufman, Jonathan L.;
- White, Darrell;
- Cook, Gordon;
- Rizzo, Maria;
- Xu, Yingxin;
- Fahrbach, Kyle;
- Gaudig, Maren;
- Slavcev, Mary;
- Dearden, Lindsay;
- Lam, Annette
Publication type:
journal article
High-risk Multiple Myeloma: Definition and Management.
Published in:
2017
By:
- Joseph, Nisha S.;
- Gentili, Silvia;
- Kaufman, Jonathan L.;
- Lonial, Sagar;
- Nooka, Ajay K.
Publication type:
journal article
Daratumumab, Lenalidomide and Dexamethasone (DRd) vs Lenalidomide and Dexamethasone (Rd) in RRMM Based on Prior Lines and Treatment Exposure: POLLUX.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e116, doi. 10.1016/j.clml.2017.03.211
By:
- Dimopoulos, Meletios;
- Belch, Andrew R.;
- White, Darrell J.;
- Benboubker, Lofti;
- Cook, Gordon;
- Leiba, Merav;
- Morton, James;
- Ho, P. Joy;
- Kim, Kihyun;
- Takezako, Naoki;
- San-Miguel, Jesus;
- Moreau, Philippe;
- Kaufman, Jonathan L.;
- Sutherland, Heather;
- Lalancette, Marc;
- Magen, Hila;
- Iida, Shinsuke;
- Kim, Jin Seok;
- Prince, H. Miles;
- Cochrane, Tara
Publication type:
Article
Venetoclax as Targeted Therapy for Relapsed/Refractory Multiple Myeloma.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e27, doi. 10.1016/j.clml.2017.03.046
By:
- Kumar, Shaji;
- Kaufman, Jonathan L.;
- Mikhael, Joseph;
- Gasparetto, Cristina;
- Vij, Ravi;
- Pegourie, Brigitte;
- Benboubker, Lofti;
- Facon, Thierry;
- Moreau, Philippe;
- Amiot, Martine;
- Alzate, Stefanie;
- Dunbar, Martin;
- Xu, Tu;
- Agarwal, Suresh;
- Leverson, Joel;
- Ross, Jeremy;
- Maciag, Paulo;
- Verdugo, Maria;
- Touzeau, Cyrille
Publication type:
Article
Efficacy and Safety of Daratumumab-Based Regimens in Patients with Relapsed/Refractory Multiple Myeloma – A Systematic Literature Review and Network Meta-analysis.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e63, doi. 10.1016/j.clml.2017.03.115
By:
- Dimopoulos, Meletios;
- Weisel, Katja;
- Kaufman, Jonathan L.;
- Sonneveld, Pieter;
- Rizzo, Maria;
- Xu, Yingxin;
- Fahrbach, Kyle;
- Gaudig, Maren;
- Slavcev, Mary;
- Lam, Annette
Publication type:
Article
Survival Outcomes of Younger (≤ 50 years) Myeloma Patients.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e119, doi. 10.1016/j.clml.2017.03.216
By:
- Almaula, Dhwani;
- Joseph, Nisha;
- Kaufman, Jonathan L.;
- Heffner, Leonard T.;
- Liu, Yuan;
- Zhang, Chao;
- Boise, Larry;
- Lonial, Sagar;
- Nooka, Ajay
Publication type:
Article
RVD is a Superior Induction Regimen Compared to VCD Among Transplant-Eligible Myeloma Patients.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e137, doi. 10.1016/j.clml.2017.03.248
By:
- Nooka, Ajay;
- Jimenez-Zepeda, Victor;
- Boise, Larry;
- Kaufman, Jonathan L.;
- Almaula, Dhwani;
- Bahlis, Nizar J.;
- Lonial, Sagar
Publication type:
Article
Depth of Response and MRD with Daratumumab Plus Lenalidomide and Dexamethasone (DRd) vs Lenalidomide and Dexamethasone (Rd) in RRMM: POLLUX.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e17, doi. 10.1016/j.clml.2017.03.029
By:
- San-Miguel, Jesus;
- Dimopoulos, Meletios Athanasios;
- Usmani, Saad;
- Belch, Andrew R.;
- Bahlis, Nizar J.;
- White, Darrell J.;
- Benboubker, Lofti;
- Cook, Gordon;
- Leiba, Merav;
- Morton, James;
- Ho, P. Joy;
- Kim, Kihyun;
- Takezako, Naoki;
- Kaufman, Jonathan L.;
- Sutherland, Heather;
- Lalancette, Marc;
- Magen, Hila;
- Iida, Shinsuke;
- Kim, Jin Seok;
- Prince, H. Miles
Publication type:
Article
Phase 1b Study of Daratumumab plus Pomalidomide and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma (RRMM) with ≥2 Prior Lines of Therapy.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e14, doi. 10.1016/j.clml.2017.03.025
By:
- Chari, Ajai;
- Suvannasankha, Attaya;
- Fay, Joseph;
- Arnulf, Bertrand;
- Kaufman, Jonathan L.;
- Ifthikharuddin, Jainulabdeen;
- Weiss, Brendan M.;
- Krishnan, Amrita;
- Lentzsch, Suzanne;
- Comenzo, Ray;
- Wang, Jim;
- Masterson, Tara;
- Nottage, Kerri;
- Schecter, Jordan;
- Chiu, Christopher;
- Khokhar, Nushmia;
- Ahmadi, Tahamtan;
- Lonial, Sagar
Publication type:
Article
VANTAGE 095: An International, Multicenter, Open-Label Study of Vorinostat (MK-0683) in Combination With Bortezomib in Patients With Relapsed and Refractory Multiple Myeloma.
Published in:
2016
By:
- Siegel, David S.;
- Dimopoulos, Meletios;
- Jagannath, Sundar;
- Goldschmidt, Hartmut;
- Durrant, Simon;
- Kaufman, Jonathan L.;
- Leleu, Xavier;
- Nagler, Arnon;
- Offner, Fritz;
- Graef, Thorsten;
- Eid, Joseph E.;
- Houp, Jennifer;
- Gause, Christine;
- Vuocolo, Scott;
- Anderson, Kenneth C.
Publication type:
journal article
Pharmacokinetics and Safety of Elotuzumab Combined With Lenalidomide and Dexamethasone in Patients With Multiple Myeloma and Various Levels of Renal Impairment: Results of a Phase Ib Study.
Published in:
2016
By:
- Berdeja, Jesus;
- Jagannath, Sundar;
- Zonder, Jeffrey;
- Badros, Ashraf;
- Kaufman, Jonathan L.;
- Manges, Robert;
- Gupta, Manish;
- Tendolkar, Amol;
- Lynch, Mark;
- Bleickardt, Eric;
- Paliwal, Prashni;
- Vij, Ravi
Publication type:
journal article
Eliminating the monitoring period with subcutaneous daratumumab: a single-center experience.
Published in:
Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00801-1
By:
- Maples, Kathryn T.;
- Hall, Kevin H.;
- Joseph, Nisha S.;
- Hofmeister, Craig C.;
- Gupta, Vikas;
- Dhodapkar, Madhav V.;
- Kaufman, Jonathan L.;
- Nooka, Ajay K.;
- Lonial, Sagar
Publication type:
Article
Eliminating the monitoring period with subcutaneous daratumumab: a single-center experience.
Published in:
2023
By:
- Maples, Kathryn T.;
- Hall, Kevin H.;
- Joseph, Nisha S.;
- Hofmeister, Craig C.;
- Gupta, Vikas;
- Dhodapkar, Madhav V.;
- Kaufman, Jonathan L.;
- Nooka, Ajay K.;
- Lonial, Sagar
Publication type:
Letter
Venetoclax ex vivo functional profiling predicts improved progression-free survival.
Published in:
Blood Cancer Journal, 2022, v. 12, n. 8, p. 1, doi. 10.1038/s41408-022-00710-9
By:
- Gupta, Vikas A.;
- Matulis, Shannon M.;
- Barwick, Benjamin G.;
- Bog, R. Devin;
- Shebelut, Conrad W.;
- Shanmugam, Mala;
- Neri, Paola;
- Bahlis, Nizar J.;
- Dhodapkar, Madhav V.;
- Heffner, Leonard T.;
- Hofmeister, Craig C.;
- Joseph, Nisha S.;
- Lonial, Sagar;
- Kaufman, Jonathan L.;
- Jaye, David L.;
- Nooka, Ajay K.;
- Boise, Lawrence H.
Publication type:
Article
Daratumumab plus lenalidomide/bortezomib/dexamethasone in Black patients with transplant-eligible newly diagnosed multiple myeloma in GRIFFIN.
Published in:
2022
By:
- Nooka, Ajay K.;
- Kaufman, Jonathan L.;
- Rodriguez, Cesar;
- Jakubowiak, Andrzej;
- Efebera, Yvonne;
- Reeves, Brandi;
- Wildes, Tanya;
- Holstein, Sarah A.;
- Anderson Jr, Larry D.;
- Badros, Ashraf;
- Shune, Leyla;
- Chari, Ajai;
- Pei, Huiling;
- Cortoos, Annelore;
- Patel, Sharmila;
- Bartlett, J. Blake;
- Vermeulen, Jessica;
- Lin, Thomas S.;
- Richardson, Paul G.;
- Voorhees, Peter
Publication type:
Letter
Daratumumab, lenalidomide, and dexamethasone in relapsed/refractory myeloma: a cytogenetic subgroup analysis of POLLUX.
Published in:
Blood Cancer Journal, 2020, v. 10, n. 11, p. 1, doi. 10.1038/s41408-020-00375-2
By:
- Kaufman, Jonathan L.;
- Dimopoulos, Meletios A.;
- White, Darrell;
- Benboubker, Lotfi;
- Cook, Gordon;
- Leiba, Merav;
- Morton, James;
- Joy Ho, P.;
- Kim, Kihyun;
- Takezako, Naoki;
- Moreau, Philippe;
- Sutherland, Heather J.;
- Magen, Hila;
- Iida, Shinsuke;
- Kim, Jin Seok;
- Miles Prince, H.;
- Cochrane, Tara;
- Oriol, Albert;
- Bahlis, Nizar J.;
- Chari, Ajai
Publication type:
Article
Clinical features and survival of multiple myeloma patients harboring t(14;16) in the era of novel agents.
Published in:
2020
By:
- Mina, Roberto;
- Joseph, Nisha S.;
- Gay, Francesca;
- Kastritis, Efstathios;
- Petrucci, Maria Teresa;
- Kaufman, Jonathan L.;
- Montefusco, Vittorio;
- Gavriatopoulou, Maria;
- Patriarca, Francesca;
- Omedé, Paola;
- Boise, Lawrence H.;
- Roussou, Maria;
- Giuliani, Nicola;
- Oliva, Stefania;
- Offidani, Massimo;
- Belotti, Angelo;
- Jaye, David L.;
- De Paoli, Lorenzo;
- Terpos, Evangelos;
- Lonial, Sagar
Publication type:
Letter
Gain of Chromosome 1q is associated with early progression in multiple myeloma patients treated with lenalidomide, bortezomib, and dexamethasone.
Published in:
Blood Cancer Journal, 2019, v. 9, n. 12, p. 1, doi. 10.1038/s41408-019-0254-0
By:
- Schmidt, Timothy M.;
- Barwick, Benjamin G.;
- Joseph, Nisha;
- Heffner, Leonard T.;
- Hofmeister, Craig C.;
- Bernal, Leon;
- Dhodapkar, Madhav V.;
- Gupta, Vikas A.;
- Jaye, David L.;
- Wu, Jiayi;
- Goyal, Subir;
- Chen, Zhengjia;
- Boise, Lawrence H.;
- Lonial, Sagar;
- Nooka, Ajay K.;
- Kaufman, Jonathan L.
Publication type:
Article

Found: 76